Clinical Trials
23 trialsNCT02557061 2026-04-16
TIL
University Hospital, Rouen
Phase NA Completed
NCT02872779 2026-04-16
COCA-MACS
University Hospital, Rouen
Phase NA Completed
NCT03958747 2026-03-19
Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy
Wake Forest University Health Sciences
Phase NA Completed
NCT05520840 2026-02-06
COLODIAG
University Hospital, Rouen
Phase NA Completed
NCT03969784 2025-11-20
MICROCOL
Assistance Publique Hopitaux De Marseille
Phase NA Completed
NCT02556281 2025-10-06
CTC
University Hospital, Rouen
Phase NA Completed
NCT05090215 2025-07-16
POSTEx
University of Nottingham
Phase NA Completed
NCT06404593 2024-05-08
Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases
Peking University Cancer Hospital & Institute
Completed
NCT04394572 2022-10-10
EXOSCOL01
CHU de Reims
Completed
NCT04659018 2022-08-31
COLODIAG pre
Centre Hospitalier Universitaire Dijon
Completed
NCT02907086 2022-06-06
Circulating Tumor Material in Colorectal Cancer and Melanoma
Abramson Cancer Center at Penn Medicine
Completed
NCT01591590 2021-10-26
CORIOLAN
Jules Bordet Institute
Phase NA Completed
NCT04425564 2020-06-11
Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer Patients
National Cancer Institute, Egypt
Phase 2 Completed
NCT03706248 2020-02-13
PASCAL
Clinical Genomics Pathology
Completed
NCT02199912 2018-11-23
ANC2
Hospices Civils de Lyon
Phase NA Completed
NCT02364154 2018-08-21
BIOCOR
Hasselt University
Completed
NCT01212510 2016-08-17
Coca-Colon
University Hospital, Rouen
Phase NA Completed
NCT01405430 2015-06-29
AVECC
Centre Leon Berard
Phase NA Completed
NCT01579357 2015-03-09
Pharmacokinetics and Metabolic Activation of Capecitabine
Arbeitsgemeinschaft medikamentoese Tumortherapie
Phase 2 Completed
NCT00855348 2014-08-04
PRESEPT
Epigenomics, Inc
Completed
NCT01329718 2014-08-04
SPR0012
Epigenomics, Inc
Phase EARLY_PHASE1 Completed
NCT01902849 2014-03-11
T-IL-Co-ReCa
Iuliu Hatieganu University of Medicine and Pharmacy
Completed
NCT00140036 2008-03-03
Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).
Pfizer
Phase 4 Completed